Detalhe da pesquisa
1.
Tumor necrosis factor-α blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation.
Immunity
; 38(3): 541-54, 2013 Mar 21.
Artigo
Inglês
| MEDLINE | ID: mdl-23477736
2.
Impaired SNX9 Expression in Immune Cells during Chronic Inflammation: Prognostic and Diagnostic Implications.
J Immunol
; 196(1): 156-67, 2016 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26608909
3.
Chronic inflammation and cancer: suppressing the suppressors.
Cancer Immunol Immunother
; 63(1): 11-20, 2014 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-23990173
4.
New insights into chronic inflammation-induced immunosuppression.
Semin Cancer Biol
; 22(4): 307-18, 2012 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-22387003
5.
Clinical Significance of Circulating CD33+CD11b+HLA-DR- Myeloid Cells in Patients with Stage IV Melanoma Treated with Ipilimumab.
Clin Cancer Res
; 22(23): 5661-5672, 2016 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27178742
6.
RNF20 Links Histone H2B Ubiquitylation with Inflammation and Inflammation-Associated Cancer.
Cell Rep
; 14(6): 1462-1476, 2016 Feb 16.
Artigo
Inglês
| MEDLINE | ID: mdl-26854224
7.
Paving the Road to Tumor Development and Spreading: Myeloid-Derived Suppressor Cells are Ruling the Fate.
Front Immunol
; 6: 523, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26528286
8.
Adverse immunoregulatory effects of 5FU and CPT11 chemotherapy on myeloid-derived suppressor cells and colorectal cancer outcomes.
Cancer Res
; 74(21): 6022-35, 2014 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25209187
9.
Cyclophosphamide promotes chronic inflammation-dependent immunosuppression and prevents antitumor response in melanoma.
J Invest Dermatol
; 133(6): 1610-9, 2013 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-23223128